Ultrahuman lines up $60M Series C led by Qualcomm Ventures at $363M valuation
Mumbai-based wearable-tech brand Ultrahuman is raising Rs 583 crore ($60 million) in a Qualcomm Ventures-led Series C. The round would value the company at about $363 million, 65% above its Series B valuation, and fund growth and expansion. Ultrahuman reported FY25 revenue of Rs 565 crore and is targeting Rs 1,000 crore in FY26.
What happened
Indian wearable-tech brand Ultrahuman is raising Rs 583 crore ($60 million) in a Qualcomm Ventures-led Series C, valuing it at about $363 million. The company
Key facts
- Rs 583 crore ($60 million) Series C round
- Qualcomm Ventures: Rs 143 crore
- Alpha Wave: Rs 114 crore
- Laboratory Corporation of America Holdings: Rs 95 crore
- Blume Ventures: Rs 90 crore
- Post-money valuation: about $363 million
- Valuation increase: 65% versus Series B
- FY25 revenue: Rs 565 crore
- FY25 profit after tax: Rs 73 crore
- FY26 revenue projection: Rs 1,000 crore
Why this matters
Qualcomm Ventures’ lead investment validates Ultrahuman’s strategic relevance in connected health, making the company a more credible partnership, distribution or acquisition target for consumer-tech and wellness platforms.
What to watch
- Formal closing terms, final round size and confirmation of Qualcomm Ventures' participation.
- Evidence of distribution deals with major electronics, pharmacy, department-store or fitness retail chains.
- FY26 revenue run rate versus the Rs 1,000 crore target, especially growth in international sales.
- Gross-margin trends, marketing spend, inventory days and cash burn following the raise.
- New device launches, regulatory/clinical claims and subscription attach-rate disclosures.
- Competitive price cuts, new ring launches or retail promotions from Oura, Samsung, Apple, Garmin and Indian wearable brands.
- Expand retail distribution beyond direct-to-consumer channels, prioritizing premium electronics, fitness, pharmacy and airport/travel retail partners.
- Use Qualcomm Ventures affiliation to strengthen chipset, sensor, AI and health-data product positioning while accelerating next-generation device launches.
- Increase international market entry spending, likely through localized e-commerce, marketplace listings and selective offline channel partnerships.
- Build higher-margin recurring revenue through subscriptions, metabolic-health programs, coaching, app features and accessory bundles.
- Use funding to secure component supply and inventory ahead of broader retail rollout, reducing stockout risk during expansion.